Global Radionuclide Drug Conjugates (RDC) Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Radionuclide Drug Conjugates (RDC) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radionuclide Drug Conjugates (RDC) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radionuclide Drug Conjugates (RDC) market in any manner.
Global Radionuclide Drug Conjugates (RDC) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
POINT Biopharma
Telix
ITM AG
Bayer AG
Novartis
Lantheus
Curium Pharma
Uihc Pet Imaging
Grand Pharma
BoomRay Pharmaceuticals
SmartNuclide Biopharma
Hengrui Medicine
Yunnan Baiyao Group
Sinotau
Hexin Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Market Segmentation (by Type)
Antibody Radionuclide Conjugates (ARC)
Peptide Radionuclide Conjugates (PRC)
Small Molecular Radionuclide Conjugates (SMRC)
Market Segmentation (by Application)
Neuroendocrine Tumors
Prostate Cancer
Renal Cell Carcinoma
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radionuclide Drug Conjugates (RDC) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Radionuclide Drug Conjugates (RDC) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radionuclide Drug Conjugates (RDC) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radionuclide Drug Conjugates (RDC) market in any manner.
Global Radionuclide Drug Conjugates (RDC) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
POINT Biopharma
Telix
ITM AG
Bayer AG
Novartis
Lantheus
Curium Pharma
Uihc Pet Imaging
Grand Pharma
BoomRay Pharmaceuticals
SmartNuclide Biopharma
Hengrui Medicine
Yunnan Baiyao Group
Sinotau
Hexin Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Market Segmentation (by Type)
Antibody Radionuclide Conjugates (ARC)
Peptide Radionuclide Conjugates (PRC)
Small Molecular Radionuclide Conjugates (SMRC)
Market Segmentation (by Application)
Neuroendocrine Tumors
Prostate Cancer
Renal Cell Carcinoma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Radionuclide Drug Conjugates (RDC) Market
- Overview of the regional outlook of the Radionuclide Drug Conjugates (RDC) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radionuclide Drug Conjugates (RDC) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radionuclide Drug Conjugates (RDC)
1.2 Key Market Segments
1.2.1 Radionuclide Drug Conjugates (RDC) Segment by Type
1.2.2 Radionuclide Drug Conjugates (RDC) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radionuclide Drug Conjugates (RDC) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET COMPETITIVE LANDSCAPE
3.1 Global Radionuclide Drug Conjugates (RDC) Sales by Manufacturers (2019-2024)
3.2 Global Radionuclide Drug Conjugates (RDC) Revenue Market Share by Manufacturers (2019-2024)
3.3 Radionuclide Drug Conjugates (RDC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radionuclide Drug Conjugates (RDC) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radionuclide Drug Conjugates (RDC) Sales Sites, Area Served, Product Type
3.6 Radionuclide Drug Conjugates (RDC) Market Competitive Situation and Trends
3.6.1 Radionuclide Drug Conjugates (RDC) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radionuclide Drug Conjugates (RDC) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIONUCLIDE DRUG CONJUGATES (RDC) INDUSTRY CHAIN ANALYSIS
4.1 Radionuclide Drug Conjugates (RDC) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Type (2019-2024)
6.3 Global Radionuclide Drug Conjugates (RDC) Market Size Market Share by Type (2019-2024)
6.4 Global Radionuclide Drug Conjugates (RDC) Price by Type (2019-2024)
7 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radionuclide Drug Conjugates (RDC) Market Sales by Application (2019-2024)
7.3 Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) by Application (2019-2024)
7.4 Global Radionuclide Drug Conjugates (RDC) Sales Growth Rate by Application (2019-2024)
8 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET SEGMENTATION BY REGION
8.1 Global Radionuclide Drug Conjugates (RDC) Sales by Region
8.1.1 Global Radionuclide Drug Conjugates (RDC) Sales by Region
8.1.2 Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Region
8.2 North America
8.2.1 North America Radionuclide Drug Conjugates (RDC) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radionuclide Drug Conjugates (RDC) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radionuclide Drug Conjugates (RDC) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radionuclide Drug Conjugates (RDC) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 POINT Biopharma
9.1.1 POINT Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
9.1.2 POINT Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
9.1.3 POINT Biopharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.1.4 POINT Biopharma Business Overview
9.1.5 POINT Biopharma Radionuclide Drug Conjugates (RDC) SWOT Analysis
9.1.6 POINT Biopharma Recent Developments
9.2 Telix
9.2.1 Telix Radionuclide Drug Conjugates (RDC) Basic Information
9.2.2 Telix Radionuclide Drug Conjugates (RDC) Product Overview
9.2.3 Telix Radionuclide Drug Conjugates (RDC) Product Market Performance
9.2.4 Telix Business Overview
9.2.5 Telix Radionuclide Drug Conjugates (RDC) SWOT Analysis
9.2.6 Telix Recent Developments
9.3 ITM AG
9.3.1 ITM AG Radionuclide Drug Conjugates (RDC) Basic Information
9.3.2 ITM AG Radionuclide Drug Conjugates (RDC) Product Overview
9.3.3 ITM AG Radionuclide Drug Conjugates (RDC) Product Market Performance
9.3.4 ITM AG Radionuclide Drug Conjugates (RDC) SWOT Analysis
9.3.5 ITM AG Business Overview
9.3.6 ITM AG Recent Developments
9.4 Bayer AG
9.4.1 Bayer AG Radionuclide Drug Conjugates (RDC) Basic Information
9.4.2 Bayer AG Radionuclide Drug Conjugates (RDC) Product Overview
9.4.3 Bayer AG Radionuclide Drug Conjugates (RDC) Product Market Performance
9.4.4 Bayer AG Business Overview
9.4.5 Bayer AG Recent Developments
9.5 Novartis
9.5.1 Novartis Radionuclide Drug Conjugates (RDC) Basic Information
9.5.2 Novartis Radionuclide Drug Conjugates (RDC) Product Overview
9.5.3 Novartis Radionuclide Drug Conjugates (RDC) Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radionuclide Drug Conjugates (RDC) Basic Information
9.6.2 Lantheus Radionuclide Drug Conjugates (RDC) Product Overview
9.6.3 Lantheus Radionuclide Drug Conjugates (RDC) Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 Curium Pharma
9.7.1 Curium Pharma Radionuclide Drug Conjugates (RDC) Basic Information
9.7.2 Curium Pharma Radionuclide Drug Conjugates (RDC) Product Overview
9.7.3 Curium Pharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.7.4 Curium Pharma Business Overview
9.7.5 Curium Pharma Recent Developments
9.8 Uihc Pet Imaging
9.8.1 Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Basic Information
9.8.2 Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Product Overview
9.8.3 Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Product Market Performance
9.8.4 Uihc Pet Imaging Business Overview
9.8.5 Uihc Pet Imaging Recent Developments
9.9 Grand Pharma
9.9.1 Grand Pharma Radionuclide Drug Conjugates (RDC) Basic Information
9.9.2 Grand Pharma Radionuclide Drug Conjugates (RDC) Product Overview
9.9.3 Grand Pharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.9.4 Grand Pharma Business Overview
9.9.5 Grand Pharma Recent Developments
9.10 BoomRay Pharmaceuticals
9.10.1 BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Basic Information
9.10.2 BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Product Overview
9.10.3 BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Product Market Performance
9.10.4 BoomRay Pharmaceuticals Business Overview
9.10.5 BoomRay Pharmaceuticals Recent Developments
9.11 SmartNuclide Biopharma
9.11.1 SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
9.11.2 SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
9.11.3 SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.11.4 SmartNuclide Biopharma Business Overview
9.11.5 SmartNuclide Biopharma Recent Developments
9.12 Hengrui Medicine
9.12.1 Hengrui Medicine Radionuclide Drug Conjugates (RDC) Basic Information
9.12.2 Hengrui Medicine Radionuclide Drug Conjugates (RDC) Product Overview
9.12.3 Hengrui Medicine Radionuclide Drug Conjugates (RDC) Product Market Performance
9.12.4 Hengrui Medicine Business Overview
9.12.5 Hengrui Medicine Recent Developments
9.13 Yunnan Baiyao Group
9.13.1 Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Basic Information
9.13.2 Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Product Overview
9.13.3 Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Product Market Performance
9.13.4 Yunnan Baiyao Group Business Overview
9.13.5 Yunnan Baiyao Group Recent Developments
9.14 Sinotau
9.14.1 Sinotau Radionuclide Drug Conjugates (RDC) Basic Information
9.14.2 Sinotau Radionuclide Drug Conjugates (RDC) Product Overview
9.14.3 Sinotau Radionuclide Drug Conjugates (RDC) Product Market Performance
9.14.4 Sinotau Business Overview
9.14.5 Sinotau Recent Developments
9.15 Hexin Pharmaceutical
9.15.1 Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Basic Information
9.15.2 Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Product Overview
9.15.3 Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Product Market Performance
9.15.4 Hexin Pharmaceutical Business Overview
9.15.5 Hexin Pharmaceutical Recent Developments
9.16 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
9.16.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Basic Information
9.16.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Product Overview
9.16.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Product Market Performance
9.16.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
9.16.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
10 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET FORECAST BY REGION
10.1 Global Radionuclide Drug Conjugates (RDC) Market Size Forecast
10.2 Global Radionuclide Drug Conjugates (RDC) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country
10.2.3 Asia Pacific Radionuclide Drug Conjugates (RDC) Market Size Forecast by Region
10.2.4 South America Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radionuclide Drug Conjugates (RDC) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Radionuclide Drug Conjugates (RDC) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radionuclide Drug Conjugates (RDC) by Type (2025-2030)
11.1.2 Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radionuclide Drug Conjugates (RDC) by Type (2025-2030)
11.2 Global Radionuclide Drug Conjugates (RDC) Market Forecast by Application (2025-2030)
11.2.1 Global Radionuclide Drug Conjugates (RDC) Sales (K Units) Forecast by Application
11.2.2 Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radionuclide Drug Conjugates (RDC)
1.2 Key Market Segments
1.2.1 Radionuclide Drug Conjugates (RDC) Segment by Type
1.2.2 Radionuclide Drug Conjugates (RDC) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radionuclide Drug Conjugates (RDC) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET COMPETITIVE LANDSCAPE
3.1 Global Radionuclide Drug Conjugates (RDC) Sales by Manufacturers (2019-2024)
3.2 Global Radionuclide Drug Conjugates (RDC) Revenue Market Share by Manufacturers (2019-2024)
3.3 Radionuclide Drug Conjugates (RDC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radionuclide Drug Conjugates (RDC) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radionuclide Drug Conjugates (RDC) Sales Sites, Area Served, Product Type
3.6 Radionuclide Drug Conjugates (RDC) Market Competitive Situation and Trends
3.6.1 Radionuclide Drug Conjugates (RDC) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radionuclide Drug Conjugates (RDC) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIONUCLIDE DRUG CONJUGATES (RDC) INDUSTRY CHAIN ANALYSIS
4.1 Radionuclide Drug Conjugates (RDC) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Type (2019-2024)
6.3 Global Radionuclide Drug Conjugates (RDC) Market Size Market Share by Type (2019-2024)
6.4 Global Radionuclide Drug Conjugates (RDC) Price by Type (2019-2024)
7 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radionuclide Drug Conjugates (RDC) Market Sales by Application (2019-2024)
7.3 Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) by Application (2019-2024)
7.4 Global Radionuclide Drug Conjugates (RDC) Sales Growth Rate by Application (2019-2024)
8 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET SEGMENTATION BY REGION
8.1 Global Radionuclide Drug Conjugates (RDC) Sales by Region
8.1.1 Global Radionuclide Drug Conjugates (RDC) Sales by Region
8.1.2 Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Region
8.2 North America
8.2.1 North America Radionuclide Drug Conjugates (RDC) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radionuclide Drug Conjugates (RDC) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radionuclide Drug Conjugates (RDC) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radionuclide Drug Conjugates (RDC) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 POINT Biopharma
9.1.1 POINT Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
9.1.2 POINT Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
9.1.3 POINT Biopharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.1.4 POINT Biopharma Business Overview
9.1.5 POINT Biopharma Radionuclide Drug Conjugates (RDC) SWOT Analysis
9.1.6 POINT Biopharma Recent Developments
9.2 Telix
9.2.1 Telix Radionuclide Drug Conjugates (RDC) Basic Information
9.2.2 Telix Radionuclide Drug Conjugates (RDC) Product Overview
9.2.3 Telix Radionuclide Drug Conjugates (RDC) Product Market Performance
9.2.4 Telix Business Overview
9.2.5 Telix Radionuclide Drug Conjugates (RDC) SWOT Analysis
9.2.6 Telix Recent Developments
9.3 ITM AG
9.3.1 ITM AG Radionuclide Drug Conjugates (RDC) Basic Information
9.3.2 ITM AG Radionuclide Drug Conjugates (RDC) Product Overview
9.3.3 ITM AG Radionuclide Drug Conjugates (RDC) Product Market Performance
9.3.4 ITM AG Radionuclide Drug Conjugates (RDC) SWOT Analysis
9.3.5 ITM AG Business Overview
9.3.6 ITM AG Recent Developments
9.4 Bayer AG
9.4.1 Bayer AG Radionuclide Drug Conjugates (RDC) Basic Information
9.4.2 Bayer AG Radionuclide Drug Conjugates (RDC) Product Overview
9.4.3 Bayer AG Radionuclide Drug Conjugates (RDC) Product Market Performance
9.4.4 Bayer AG Business Overview
9.4.5 Bayer AG Recent Developments
9.5 Novartis
9.5.1 Novartis Radionuclide Drug Conjugates (RDC) Basic Information
9.5.2 Novartis Radionuclide Drug Conjugates (RDC) Product Overview
9.5.3 Novartis Radionuclide Drug Conjugates (RDC) Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radionuclide Drug Conjugates (RDC) Basic Information
9.6.2 Lantheus Radionuclide Drug Conjugates (RDC) Product Overview
9.6.3 Lantheus Radionuclide Drug Conjugates (RDC) Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 Curium Pharma
9.7.1 Curium Pharma Radionuclide Drug Conjugates (RDC) Basic Information
9.7.2 Curium Pharma Radionuclide Drug Conjugates (RDC) Product Overview
9.7.3 Curium Pharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.7.4 Curium Pharma Business Overview
9.7.5 Curium Pharma Recent Developments
9.8 Uihc Pet Imaging
9.8.1 Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Basic Information
9.8.2 Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Product Overview
9.8.3 Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Product Market Performance
9.8.4 Uihc Pet Imaging Business Overview
9.8.5 Uihc Pet Imaging Recent Developments
9.9 Grand Pharma
9.9.1 Grand Pharma Radionuclide Drug Conjugates (RDC) Basic Information
9.9.2 Grand Pharma Radionuclide Drug Conjugates (RDC) Product Overview
9.9.3 Grand Pharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.9.4 Grand Pharma Business Overview
9.9.5 Grand Pharma Recent Developments
9.10 BoomRay Pharmaceuticals
9.10.1 BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Basic Information
9.10.2 BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Product Overview
9.10.3 BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Product Market Performance
9.10.4 BoomRay Pharmaceuticals Business Overview
9.10.5 BoomRay Pharmaceuticals Recent Developments
9.11 SmartNuclide Biopharma
9.11.1 SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
9.11.2 SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
9.11.3 SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Product Market Performance
9.11.4 SmartNuclide Biopharma Business Overview
9.11.5 SmartNuclide Biopharma Recent Developments
9.12 Hengrui Medicine
9.12.1 Hengrui Medicine Radionuclide Drug Conjugates (RDC) Basic Information
9.12.2 Hengrui Medicine Radionuclide Drug Conjugates (RDC) Product Overview
9.12.3 Hengrui Medicine Radionuclide Drug Conjugates (RDC) Product Market Performance
9.12.4 Hengrui Medicine Business Overview
9.12.5 Hengrui Medicine Recent Developments
9.13 Yunnan Baiyao Group
9.13.1 Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Basic Information
9.13.2 Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Product Overview
9.13.3 Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Product Market Performance
9.13.4 Yunnan Baiyao Group Business Overview
9.13.5 Yunnan Baiyao Group Recent Developments
9.14 Sinotau
9.14.1 Sinotau Radionuclide Drug Conjugates (RDC) Basic Information
9.14.2 Sinotau Radionuclide Drug Conjugates (RDC) Product Overview
9.14.3 Sinotau Radionuclide Drug Conjugates (RDC) Product Market Performance
9.14.4 Sinotau Business Overview
9.14.5 Sinotau Recent Developments
9.15 Hexin Pharmaceutical
9.15.1 Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Basic Information
9.15.2 Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Product Overview
9.15.3 Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Product Market Performance
9.15.4 Hexin Pharmaceutical Business Overview
9.15.5 Hexin Pharmaceutical Recent Developments
9.16 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
9.16.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Basic Information
9.16.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Product Overview
9.16.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Product Market Performance
9.16.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
9.16.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
10 RADIONUCLIDE DRUG CONJUGATES (RDC) MARKET FORECAST BY REGION
10.1 Global Radionuclide Drug Conjugates (RDC) Market Size Forecast
10.2 Global Radionuclide Drug Conjugates (RDC) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country
10.2.3 Asia Pacific Radionuclide Drug Conjugates (RDC) Market Size Forecast by Region
10.2.4 South America Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radionuclide Drug Conjugates (RDC) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Radionuclide Drug Conjugates (RDC) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radionuclide Drug Conjugates (RDC) by Type (2025-2030)
11.1.2 Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radionuclide Drug Conjugates (RDC) by Type (2025-2030)
11.2 Global Radionuclide Drug Conjugates (RDC) Market Forecast by Application (2025-2030)
11.2.1 Global Radionuclide Drug Conjugates (RDC) Sales (K Units) Forecast by Application
11.2.2 Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radionuclide Drug Conjugates (RDC) Market Size Comparison by Region (M USD)
Table 5. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Radionuclide Drug Conjugates (RDC) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Radionuclide Drug Conjugates (RDC) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radionuclide Drug Conjugates (RDC) as of 2022)
Table 10. Global Market Radionuclide Drug Conjugates (RDC) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Radionuclide Drug Conjugates (RDC) Sales Sites and Area Served
Table 12. Manufacturers Radionuclide Drug Conjugates (RDC) Product Type
Table 13. Global Radionuclide Drug Conjugates (RDC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radionuclide Drug Conjugates (RDC)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radionuclide Drug Conjugates (RDC) Market Challenges
Table 22. Global Radionuclide Drug Conjugates (RDC) Sales by Type (K Units)
Table 23. Global Radionuclide Drug Conjugates (RDC) Market Size by Type (M USD)
Table 24. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) by Type (2019-2024)
Table 25. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Type (2019-2024)
Table 26. Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) by Type (2019-2024)
Table 27. Global Radionuclide Drug Conjugates (RDC) Market Size Share by Type (2019-2024)
Table 28. Global Radionuclide Drug Conjugates (RDC) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) by Application
Table 30. Global Radionuclide Drug Conjugates (RDC) Market Size by Application
Table 31. Global Radionuclide Drug Conjugates (RDC) Sales by Application (2019-2024) & (K Units)
Table 32. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Application (2019-2024)
Table 33. Global Radionuclide Drug Conjugates (RDC) Sales by Application (2019-2024) & (M USD)
Table 34. Global Radionuclide Drug Conjugates (RDC) Market Share by Application (2019-2024)
Table 35. Global Radionuclide Drug Conjugates (RDC) Sales Growth Rate by Application (2019-2024)
Table 36. Global Radionuclide Drug Conjugates (RDC) Sales by Region (2019-2024) & (K Units)
Table 37. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Region (2019-2024)
Table 38. North America Radionuclide Drug Conjugates (RDC) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Radionuclide Drug Conjugates (RDC) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales by Region (2019-2024) & (K Units)
Table 41. South America Radionuclide Drug Conjugates (RDC) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales by Region (2019-2024) & (K Units)
Table 43. POINT Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 44. POINT Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 45. POINT Biopharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. POINT Biopharma Business Overview
Table 47. POINT Biopharma Radionuclide Drug Conjugates (RDC) SWOT Analysis
Table 48. POINT Biopharma Recent Developments
Table 49. Telix Radionuclide Drug Conjugates (RDC) Basic Information
Table 50. Telix Radionuclide Drug Conjugates (RDC) Product Overview
Table 51. Telix Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Telix Business Overview
Table 53. Telix Radionuclide Drug Conjugates (RDC) SWOT Analysis
Table 54. Telix Recent Developments
Table 55. ITM AG Radionuclide Drug Conjugates (RDC) Basic Information
Table 56. ITM AG Radionuclide Drug Conjugates (RDC) Product Overview
Table 57. ITM AG Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ITM AG Radionuclide Drug Conjugates (RDC) SWOT Analysis
Table 59. ITM AG Business Overview
Table 60. ITM AG Recent Developments
Table 61. Bayer AG Radionuclide Drug Conjugates (RDC) Basic Information
Table 62. Bayer AG Radionuclide Drug Conjugates (RDC) Product Overview
Table 63. Bayer AG Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bayer AG Business Overview
Table 65. Bayer AG Recent Developments
Table 66. Novartis Radionuclide Drug Conjugates (RDC) Basic Information
Table 67. Novartis Radionuclide Drug Conjugates (RDC) Product Overview
Table 68. Novartis Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Lantheus Radionuclide Drug Conjugates (RDC) Basic Information
Table 72. Lantheus Radionuclide Drug Conjugates (RDC) Product Overview
Table 73. Lantheus Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lantheus Business Overview
Table 75. Lantheus Recent Developments
Table 76. Curium Pharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 77. Curium Pharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 78. Curium Pharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Curium Pharma Business Overview
Table 80. Curium Pharma Recent Developments
Table 81. Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Basic Information
Table 82. Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Product Overview
Table 83. Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Uihc Pet Imaging Business Overview
Table 85. Uihc Pet Imaging Recent Developments
Table 86. Grand Pharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 87. Grand Pharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 88. Grand Pharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Grand Pharma Business Overview
Table 90. Grand Pharma Recent Developments
Table 91. BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Basic Information
Table 92. BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Product Overview
Table 93. BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BoomRay Pharmaceuticals Business Overview
Table 95. BoomRay Pharmaceuticals Recent Developments
Table 96. SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 97. SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 98. SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. SmartNuclide Biopharma Business Overview
Table 100. SmartNuclide Biopharma Recent Developments
Table 101. Hengrui Medicine Radionuclide Drug Conjugates (RDC) Basic Information
Table 102. Hengrui Medicine Radionuclide Drug Conjugates (RDC) Product Overview
Table 103. Hengrui Medicine Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Hengrui Medicine Business Overview
Table 105. Hengrui Medicine Recent Developments
Table 106. Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Basic Information
Table 107. Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Product Overview
Table 108. Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Yunnan Baiyao Group Business Overview
Table 110. Yunnan Baiyao Group Recent Developments
Table 111. Sinotau Radionuclide Drug Conjugates (RDC) Basic Information
Table 112. Sinotau Radionuclide Drug Conjugates (RDC) Product Overview
Table 113. Sinotau Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Sinotau Business Overview
Table 115. Sinotau Recent Developments
Table 116. Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Basic Information
Table 117. Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Product Overview
Table 118. Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Hexin Pharmaceutical Business Overview
Table 120. Hexin Pharmaceutical Recent Developments
Table 121. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Basic Information
Table 122. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Product Overview
Table 123. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
Table 125. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
Table 126. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Radionuclide Drug Conjugates (RDC) Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Radionuclide Drug Conjugates (RDC) Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Radionuclide Drug Conjugates (RDC) Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Radionuclide Drug Conjugates (RDC) Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Radionuclide Drug Conjugates (RDC) Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Radionuclide Drug Conjugates (RDC) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radionuclide Drug Conjugates (RDC) Market Size Comparison by Region (M USD)
Table 5. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Radionuclide Drug Conjugates (RDC) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Radionuclide Drug Conjugates (RDC) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radionuclide Drug Conjugates (RDC) as of 2022)
Table 10. Global Market Radionuclide Drug Conjugates (RDC) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Radionuclide Drug Conjugates (RDC) Sales Sites and Area Served
Table 12. Manufacturers Radionuclide Drug Conjugates (RDC) Product Type
Table 13. Global Radionuclide Drug Conjugates (RDC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radionuclide Drug Conjugates (RDC)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radionuclide Drug Conjugates (RDC) Market Challenges
Table 22. Global Radionuclide Drug Conjugates (RDC) Sales by Type (K Units)
Table 23. Global Radionuclide Drug Conjugates (RDC) Market Size by Type (M USD)
Table 24. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) by Type (2019-2024)
Table 25. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Type (2019-2024)
Table 26. Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) by Type (2019-2024)
Table 27. Global Radionuclide Drug Conjugates (RDC) Market Size Share by Type (2019-2024)
Table 28. Global Radionuclide Drug Conjugates (RDC) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) by Application
Table 30. Global Radionuclide Drug Conjugates (RDC) Market Size by Application
Table 31. Global Radionuclide Drug Conjugates (RDC) Sales by Application (2019-2024) & (K Units)
Table 32. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Application (2019-2024)
Table 33. Global Radionuclide Drug Conjugates (RDC) Sales by Application (2019-2024) & (M USD)
Table 34. Global Radionuclide Drug Conjugates (RDC) Market Share by Application (2019-2024)
Table 35. Global Radionuclide Drug Conjugates (RDC) Sales Growth Rate by Application (2019-2024)
Table 36. Global Radionuclide Drug Conjugates (RDC) Sales by Region (2019-2024) & (K Units)
Table 37. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Region (2019-2024)
Table 38. North America Radionuclide Drug Conjugates (RDC) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Radionuclide Drug Conjugates (RDC) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales by Region (2019-2024) & (K Units)
Table 41. South America Radionuclide Drug Conjugates (RDC) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales by Region (2019-2024) & (K Units)
Table 43. POINT Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 44. POINT Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 45. POINT Biopharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. POINT Biopharma Business Overview
Table 47. POINT Biopharma Radionuclide Drug Conjugates (RDC) SWOT Analysis
Table 48. POINT Biopharma Recent Developments
Table 49. Telix Radionuclide Drug Conjugates (RDC) Basic Information
Table 50. Telix Radionuclide Drug Conjugates (RDC) Product Overview
Table 51. Telix Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Telix Business Overview
Table 53. Telix Radionuclide Drug Conjugates (RDC) SWOT Analysis
Table 54. Telix Recent Developments
Table 55. ITM AG Radionuclide Drug Conjugates (RDC) Basic Information
Table 56. ITM AG Radionuclide Drug Conjugates (RDC) Product Overview
Table 57. ITM AG Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ITM AG Radionuclide Drug Conjugates (RDC) SWOT Analysis
Table 59. ITM AG Business Overview
Table 60. ITM AG Recent Developments
Table 61. Bayer AG Radionuclide Drug Conjugates (RDC) Basic Information
Table 62. Bayer AG Radionuclide Drug Conjugates (RDC) Product Overview
Table 63. Bayer AG Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bayer AG Business Overview
Table 65. Bayer AG Recent Developments
Table 66. Novartis Radionuclide Drug Conjugates (RDC) Basic Information
Table 67. Novartis Radionuclide Drug Conjugates (RDC) Product Overview
Table 68. Novartis Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Lantheus Radionuclide Drug Conjugates (RDC) Basic Information
Table 72. Lantheus Radionuclide Drug Conjugates (RDC) Product Overview
Table 73. Lantheus Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lantheus Business Overview
Table 75. Lantheus Recent Developments
Table 76. Curium Pharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 77. Curium Pharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 78. Curium Pharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Curium Pharma Business Overview
Table 80. Curium Pharma Recent Developments
Table 81. Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Basic Information
Table 82. Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Product Overview
Table 83. Uihc Pet Imaging Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Uihc Pet Imaging Business Overview
Table 85. Uihc Pet Imaging Recent Developments
Table 86. Grand Pharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 87. Grand Pharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 88. Grand Pharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Grand Pharma Business Overview
Table 90. Grand Pharma Recent Developments
Table 91. BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Basic Information
Table 92. BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Product Overview
Table 93. BoomRay Pharmaceuticals Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BoomRay Pharmaceuticals Business Overview
Table 95. BoomRay Pharmaceuticals Recent Developments
Table 96. SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Basic Information
Table 97. SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Product Overview
Table 98. SmartNuclide Biopharma Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. SmartNuclide Biopharma Business Overview
Table 100. SmartNuclide Biopharma Recent Developments
Table 101. Hengrui Medicine Radionuclide Drug Conjugates (RDC) Basic Information
Table 102. Hengrui Medicine Radionuclide Drug Conjugates (RDC) Product Overview
Table 103. Hengrui Medicine Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Hengrui Medicine Business Overview
Table 105. Hengrui Medicine Recent Developments
Table 106. Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Basic Information
Table 107. Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Product Overview
Table 108. Yunnan Baiyao Group Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Yunnan Baiyao Group Business Overview
Table 110. Yunnan Baiyao Group Recent Developments
Table 111. Sinotau Radionuclide Drug Conjugates (RDC) Basic Information
Table 112. Sinotau Radionuclide Drug Conjugates (RDC) Product Overview
Table 113. Sinotau Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Sinotau Business Overview
Table 115. Sinotau Recent Developments
Table 116. Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Basic Information
Table 117. Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Product Overview
Table 118. Hexin Pharmaceutical Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Hexin Pharmaceutical Business Overview
Table 120. Hexin Pharmaceutical Recent Developments
Table 121. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Basic Information
Table 122. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Product Overview
Table 123. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates (RDC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
Table 125. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
Table 126. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Radionuclide Drug Conjugates (RDC) Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Radionuclide Drug Conjugates (RDC) Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Radionuclide Drug Conjugates (RDC) Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Radionuclide Drug Conjugates (RDC) Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Radionuclide Drug Conjugates (RDC) Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Radionuclide Drug Conjugates (RDC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Radionuclide Drug Conjugates (RDC) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radionuclide Drug Conjugates (RDC)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radionuclide Drug Conjugates (RDC) Market Size (M USD), 2019-2030
Figure 5. Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) (2019-2030)
Figure 6. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radionuclide Drug Conjugates (RDC) Market Size by Country (M USD)
Figure 11. Radionuclide Drug Conjugates (RDC) Sales Share by Manufacturers in 2023
Figure 12. Global Radionuclide Drug Conjugates (RDC) Revenue Share by Manufacturers in 2023
Figure 13. Radionuclide Drug Conjugates (RDC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Radionuclide Drug Conjugates (RDC) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radionuclide Drug Conjugates (RDC) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radionuclide Drug Conjugates (RDC) Market Share by Type
Figure 18. Sales Market Share of Radionuclide Drug Conjugates (RDC) by Type (2019-2024)
Figure 19. Sales Market Share of Radionuclide Drug Conjugates (RDC) by Type in 2023
Figure 20. Market Size Share of Radionuclide Drug Conjugates (RDC) by Type (2019-2024)
Figure 21. Market Size Market Share of Radionuclide Drug Conjugates (RDC) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radionuclide Drug Conjugates (RDC) Market Share by Application
Figure 24. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Application (2019-2024)
Figure 25. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Application in 2023
Figure 26. Global Radionuclide Drug Conjugates (RDC) Market Share by Application (2019-2024)
Figure 27. Global Radionuclide Drug Conjugates (RDC) Market Share by Application in 2023
Figure 28. Global Radionuclide Drug Conjugates (RDC) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Region (2019-2024)
Figure 30. North America Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Radionuclide Drug Conjugates (RDC) Sales Market Share by Country in 2023
Figure 32. U.S. Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Radionuclide Drug Conjugates (RDC) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Radionuclide Drug Conjugates (RDC) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Radionuclide Drug Conjugates (RDC) Sales Market Share by Country in 2023
Figure 37. Germany Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales Market Share by Region in 2023
Figure 44. China Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (K Units)
Figure 50. South America Radionuclide Drug Conjugates (RDC) Sales Market Share by Country in 2023
Figure 51. Brazil Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Radionuclide Drug Conjugates (RDC) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Radionuclide Drug Conjugates (RDC) Market Share Forecast by Type (2025-2030)
Figure 65. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Application (2025-2030)
Figure 66. Global Radionuclide Drug Conjugates (RDC) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Radionuclide Drug Conjugates (RDC)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radionuclide Drug Conjugates (RDC) Market Size (M USD), 2019-2030
Figure 5. Global Radionuclide Drug Conjugates (RDC) Market Size (M USD) (2019-2030)
Figure 6. Global Radionuclide Drug Conjugates (RDC) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radionuclide Drug Conjugates (RDC) Market Size by Country (M USD)
Figure 11. Radionuclide Drug Conjugates (RDC) Sales Share by Manufacturers in 2023
Figure 12. Global Radionuclide Drug Conjugates (RDC) Revenue Share by Manufacturers in 2023
Figure 13. Radionuclide Drug Conjugates (RDC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Radionuclide Drug Conjugates (RDC) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radionuclide Drug Conjugates (RDC) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radionuclide Drug Conjugates (RDC) Market Share by Type
Figure 18. Sales Market Share of Radionuclide Drug Conjugates (RDC) by Type (2019-2024)
Figure 19. Sales Market Share of Radionuclide Drug Conjugates (RDC) by Type in 2023
Figure 20. Market Size Share of Radionuclide Drug Conjugates (RDC) by Type (2019-2024)
Figure 21. Market Size Market Share of Radionuclide Drug Conjugates (RDC) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radionuclide Drug Conjugates (RDC) Market Share by Application
Figure 24. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Application (2019-2024)
Figure 25. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Application in 2023
Figure 26. Global Radionuclide Drug Conjugates (RDC) Market Share by Application (2019-2024)
Figure 27. Global Radionuclide Drug Conjugates (RDC) Market Share by Application in 2023
Figure 28. Global Radionuclide Drug Conjugates (RDC) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Radionuclide Drug Conjugates (RDC) Sales Market Share by Region (2019-2024)
Figure 30. North America Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Radionuclide Drug Conjugates (RDC) Sales Market Share by Country in 2023
Figure 32. U.S. Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Radionuclide Drug Conjugates (RDC) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Radionuclide Drug Conjugates (RDC) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Radionuclide Drug Conjugates (RDC) Sales Market Share by Country in 2023
Figure 37. Germany Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Radionuclide Drug Conjugates (RDC) Sales Market Share by Region in 2023
Figure 44. China Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (K Units)
Figure 50. South America Radionuclide Drug Conjugates (RDC) Sales Market Share by Country in 2023
Figure 51. Brazil Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Radionuclide Drug Conjugates (RDC) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Radionuclide Drug Conjugates (RDC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Radionuclide Drug Conjugates (RDC) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Radionuclide Drug Conjugates (RDC) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Radionuclide Drug Conjugates (RDC) Market Share Forecast by Type (2025-2030)
Figure 65. Global Radionuclide Drug Conjugates (RDC) Sales Forecast by Application (2025-2030)
Figure 66. Global Radionuclide Drug Conjugates (RDC) Market Share Forecast by Application (2025-2030)
